Wednesday, 28 October 2026LatestVideosAboutContact
Latest
Why better data could be the key to AI-driven food R&DUP MLC Election: SP Candidate Finishes Third In Gorakhpur-Faizabad Seat After Ticket SwitchYastika Bhatia set for WBBL return as Brisbane Heat sign India starAgentic AI can cut banks' transaction monitoring workload by up to 50%, improve compliance quality: McKinseyIndia’s credit card base expands 9.5% y-o-y in September; spending moderates on high base: JefferiesSC refuses to entertain plea seeking drop-down menu for OBC castes in Census 2027Kartik Aaryan To Play Lead Role In Vivek Agnihotri's Operation Sindoor: ReportArisinfra Subsidiary Unitern Bags Third Transcon Group Mandate, Boosting DaaS Portfolio To ₹2,750 Crore GDVSarvam drives 87% of Indic AI’s 2026 funding: TracxnRashtriya Military Schools Entrance Test 2026: NTA Opens Correction Window, Check DetailsJapan eyes India for advanced surface-to-ship missiles trainingSupreme Court agrees to hear challenge to definition of ‘industry’ in new Central law
BusinessUpdated 1 hr ago

Jio makes strong debut at 21% premium to become India's second-most valuable firm

Times of India28 October 2026 at 11:59 am IST
Image: Times of India

Jio Platforms celebrated a remarkable stock market entry, debuting at Rs 1,358 per share. The IPO attracted an impressive 22.19 times oversubscription, with bids surpassing Rs 7.4 lakh crore. Following this, the firm's market capitalisation soared to around Rs 12.5 lakh crore, securing its position as India's second most valuable company.

Continue reading on Times of India

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all

India’s credit card base expands 9.5% y-o-y in September; spending moderates on high base: Jefferies

BusinessLine11 min ago

Sarvam drives 87% of Indic AI’s 2026 funding: Tracxn

BusinessLine21 min ago

Supreme Court agrees to hear challenge to definition of ‘industry’ in new Central law

The Hindu24 min ago

IT stocks, Reliance drag markets lower at midday; Pharma outperforms as Fed decision looms

BusinessLine26 min ago